Nocutil (Desmopressin Acetate)

Desmopressin acetate is a synthetic analogue of the natural hormone vasopressin. It selectively activates V2 receptors in the kidney’s collecting ducts, which triggers a cascade that inserts aquaporin‑2 water channels into the cell membrane, allowing more water to be reabsorbed. The same receptor activation in endothelial cells raises plasma levels of factor VIII and von Willebrand factor, supporting clot formation.

The dose of Nocutil is individualized by the prescribing clinician based on the specific indication, patient age, weight, renal function and response to therapy. Physicians determine the appropriate strength, frequency and duration, and patients should follow the prescribed regimen without alteration.

Safety data for desmopressin acetate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers must evaluate the potential benefits against possible risks before prescribing it to pregnant or nursing women.

To request Nocutil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to desmopressin acetate is natural vasopressin (arginine vasopressin). Desmopressin has a longer half‑life, greater selectivity for V2 receptors, and a reduced risk of vasoconstrictive side effects compared with vasopressin, making it the preferred choice for most indications that require antidiuretic or hemostatic effects.

Nocutil should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct light. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.

Nocutil is formulated for oral use. The tablet (or oral solution, if supplied) should be swallowed whole with water, unless the prescribing information advises otherwise. Doses are taken at the times directed by the healthcare professional, typically with or without food as indicated.

The most critical safety concerns involve severe hyponatremia, which can lead to seizures, cerebral edema, or coma, especially when fluid intake is excessive. Rare but serious complications include thromboembolic events and severe allergic reactions such as anaphylaxis. Patients should be monitored closely for signs of electrolyte imbalance.

Nocutil is contraindicated in individuals with known hypersensitivity to desmopressin acetate, uncontrolled hyponatremia, severe renal impairment, or in patients who are taking other potent antidiuretic agents that could precipitate water intoxication. Clinicians should also exercise caution in patients with a history of thromboembolic disease.